Home › Funds › Fi3 FINANCIAL ADVISORS, LLC › LRMR
Fi3 FINANCIAL ADVISORS, LLC position in LRMR
Larimar Therapeutics Inc · Health Care
Fi3 FINANCIAL ADVISORS, LLC reported holding 2,915 shares of LRMR (Larimar Therapeutics Inc) in its Q2 2026 13F filing — a position valued at US$1.3M, representing 0.30% of its reported portfolio and ranking #34 among its reported holdings. Fi3 FINANCIAL ADVISORS, LLC has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Fi3 FINANCIAL ADVISORS, LLC's LRMR position evolved
Fi3 FINANCIAL ADVISORS, LLC first disclosed a stake in LRMR in Q3 2023 at 25,571 shares (US$101K). The position peaked in Q2 2026 at 2,915 shares, worth US$1.3M. Across 12 filings, Fi3 FINANCIAL ADVISORS, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,915 shares valued at US$1.3M — a reduction of -26,578 shares quarter over quarter.. Notable position changes include a 90% trim in Q2 2026 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 25.57K | $101.00K | New |
| Q4 2023 | 25.45K | $115.79K | Hold |
| Q1 2024 | 25.45K | $197.60K | Hold |
| Q2 2024 | 20.39K | $147.81K | Reduce |
| Q3 2024 | 20.39K | $133.53K | Hold |
| Q4 2024 | 23.80K | $92.10K | Add |
| Q1 2025 | 23.97K | $51.54K | Add |
| Q2 2025 | 24.17K | $69.86K | Add |
| Q3 2025 | 29.24K | $94.44K | Add |
| Q4 2025 | 29.32K | $111.72K | Hold |
| Q1 2026 | 29.49K | $132.72K | Add |
| Q2 2026 | 2.92K | $1.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LRMR and 13F data
LRMR (Larimar Therapeutics Inc) is a Health Care company. 26 other funds we track also report a position in LRMR — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$108.6M), Defilade Capital Management, L.P. (US$11.2M), DAFNA Capital Management LLC (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LRMR
- DEERFIELD MANAGEMENT COMPANY, L.P. 35.61M sh · $108.60M · Q2 2026
- Defilade Capital Management, L.P. 3.67M sh · $11.19M · Q2 2026
- DAFNA Capital Management LLC 2.01M sh · $6.12M · Q2 2026
More on Fi3 FINANCIAL ADVISORS, LLC
FAQ
How long has Fi3 FINANCIAL ADVISORS, LLC held LRMR?
Fi3 FINANCIAL ADVISORS, LLC has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Fi3 FINANCIAL ADVISORS, LLC's current position in LRMR?
As of Q2 2026, Fi3 FINANCIAL ADVISORS, LLC holds 2.92K shares of LRMR (Larimar Therapeutics Inc), valued at $1.26M, representing 0.30% of its reported portfolio and ranking #34.
Has Fi3 FINANCIAL ADVISORS, LLC been buying or selling LRMR?
In the latest 13F filing (Q2 2026), Fi3 FINANCIAL ADVISORS, LLC reduced its position in LRMR. The position peaked in Q2 2026 at 2.92K shares.
Which other funds hold LRMR?
Other major institutional holders of LRMR include DEERFIELD MANAGEMENT COMPANY, L.P., Defilade Capital Management, L.P., DAFNA Capital Management LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.